1、 余克明,彭大伟,刘杏,等.高三尖杉酯碱作为难治性青光眼滤过手术辅助药的临床研究——中远期临床分析[J].中国中医眼科杂志,2001(4): 202-205. 余克明,彭大伟,刘杏,等.高三尖杉酯碱作为难治性青光眼滤过手术辅助药的临床研究——中远期临床分析[J].中国中医眼科杂志,2001(4): 202-205.
2、 于丹,崔浩,李静秋,等. 中药高三尖杉脂碱在青光眼滤过术中临床应用[J].国际眼科杂志,2007(1):249-250. 于丹,崔浩,李静秋,等. 中药高三尖杉脂碱在青光眼滤过术中临床应用[J].国际眼科杂志,2007(1):249-250.
3、 胥彬.高三尖杉酯碱(Homoharringtonine)抗癌研究新进展[J].肿瘤药学,2013,(03): 162-165,231. 胥彬.高三尖杉酯碱(Homoharringtonine)抗癌研究新进展[J].肿瘤药学,2013,(03): 162-165,231.
4、 Singh RP, Goldberg I, Mohsin M. The efficacy and safety of intraoperative and/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy[J].Clinical & experimental ophthalmology,2001,29(5):296-302. Singh RP, Goldberg I, Mohsin M. The efficacy and safety of intraoperative and/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy[J].Clinical & experimental ophthalmology,2001,29(5):296-302.
5、 Palanca-Capistrano AM, Hall J, Cantor LB, et al. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery[J].Ophthalmology,2009,116(2):185-190. Palanca-Capistrano AM, Hall J, Cantor LB, et al. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery[J].Ophthalmology,2009,116(2):185-190.
6、 Singh J, O'Brien C, Chawla HB. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery[J].Eye (London, England),1995,9 (Pt 4):460-466. Singh J, O'Brien C, Chawla HB. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery[J].Eye (London, England),1995,9 (Pt 4):460-466.
7、 Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C[J].Ophthalmologe,2003, 241(2):106-110. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C[J].Ophthalmologe,2003, 241(2):106-110.
8、 Koutsonas A, Remky A, Plange N. Ophthalmologe Long-term results after trabeculectomy with 5-fluorouracil[J].Ophthalmologe,2014,111(8):749-56. Koutsonas A, Remky A, Plange N. Ophthalmologe Long-term results after trabeculectomy with 5-fluorouracil[J].Ophthalmologe,2014,111(8):749-56.
9、 Chang SW. Corneal keratocyte apoptosis following topical intrao-perative mitomycin C in rabbits[J].J Refract Surg,2005; 21(5): 446-453. Chang SW. Corneal keratocyte apoptosis following topical intrao-perative mitomycin C in rabbits[J].J Refract Surg,2005; 21(5): 446-453.
10、 Chang SW. Early corneal edema following topical application of mitomycin C[J].J Cataract Refract Surg,2004,30(8): 1742-1750. Chang SW. Early corneal edema following topical application of mitomycin C[J].J Cataract Refract Surg,2004,30(8): 1742-1750.
11、 Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolutionof filtering bleb avascularity, transconjunctival oozing, and leaks[J].Br J Ophthalmol,2006,90(2): 175-180. Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolutionof filtering bleb avascularity, transconjunctival oozing, and leaks[J].Br J Ophthalmol,2006,90(2): 175-180.
12、 Joshi AB, Parrish RK, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use[J].J Glaucoma. 2005,14(2): 172-174. Joshi AB, Parrish RK, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use[J].J Glaucoma. 2005,14(2): 172-174.
13、 Anand BJ, Richard KPII, William FF. 2002 Survey of the American glaucoma society: practice preferences for glaucoma surgery and antifibrotic use[J].J Glaucoma,2005, 14(2): 172-174. Anand BJ, Richard KPII, William FF. 2002 Survey of the American glaucoma society: practice preferences for glaucoma surgery and antifibrotic use[J].J Glaucoma,2005, 14(2): 172-174.
14、 Esson DW, Popp MP, Liu L, et al. Microarray analysis of the failure of filtering “blebs” in a rat model of glaucoma filtering surgery[J]. Invest Ophthalmol Vis Sci, 2004,(45): 4450-4462. Esson DW, Popp MP, Liu L, et al. Microarray analysis of the failure of filtering “blebs” in a rat model of glaucoma filtering surgery[J]. Invest Ophthalmol Vis Sci, 2004,(45): 4450-4462.
15、 Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery[J]. Surv Ophthalmol,2003(48):314-346. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery[J]. Surv Ophthalmol,2003(48):314-346.
16、 Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020[J]. Br J Ophthalmol,2006,90(3):262-267. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020[J]. Br J Ophthalmol,2006,90(3):262-267.
17、 Baudouin C, Denoyer A, Rostè, et al. Glaucoma today: detection and therapeutic progress[J].2013, 207 (2):87-95. Baudouin C, Denoyer A, Rostè, et al. Glaucoma today: detection and therapeutic progress[J].2013, 207 (2):87-95.
